Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
39
pubmed:dateCreated
2001-9-24
pubmed:abstractText
Transforming growth factor-beta (TGF-beta) regulates osteoclastogenesis and osteoclast survival, in part through the induction of osteoprotegerin (OPG), a protein known to inhibit osteoclast formation and function. To explore the molecular basis of TGF-beta regulation of OPG expression, we evaluated the effects of TGF-beta on osteoclast formation, OPG protein secretion, mRNA expression, and gene transcription. The marked inhibitory effect of TGF-beta on osteoclast differentiation was confirmed in a co-culture model utilizing murine stromal/osteoblastic BALC cells and bone marrow hematopoietic precursors. This inhibition in osteoclast differentiation was preceded by a decrease in RANKL mRNA expression (5-fold) and a reciprocal increase in OPG mRNA (6.1-fold) and protein (7.1-fold) expression in BALC cells. At the promoter/transcriptional level, TGF-beta treatment resulted in a 3-10-fold increase in reporter gene activity directed by a 5.9-kilobase fragment of the human OPG promoter in transfection assays performed in UMR106 cells. The effect of TGF-beta was mimicked by TGF-beta2 and -beta3 but not by BMP-4, suggesting a TGF-beta signal-specific effect. Deletion analysis revealed that a 183-base pair region (-372 to -190) in the promoter was required for TGF-beta responsiveness, and this region was sufficient to confer TGF-beta inducibility to a heterologous (osteocalcin) minimal promoter. Substitution mutations that disrupted the Cbfa1- and/or Smad-binding elements present in the 183-base pair region resulted in a decrease in base-line expression and in the responsiveness to TGF-beta and Cbfa1. Collectively, these studies indicate the involvement and possible interaction of Cbfa1 and Smad proteins in mediating the effects of TGF-beta on OPG transcription.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
0021-9258
pubmed:author
pubmed:issnType
Print
pubmed:day
28
pubmed:volume
276
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
36241-50
pubmed:dateRevised
2008-11-21
pubmed:meshHeading
pubmed-meshheading:11451955-Animals, pubmed-meshheading:11451955-Bone Marrow Cells, pubmed-meshheading:11451955-Cell Differentiation, pubmed-meshheading:11451955-Cell Line, pubmed-meshheading:11451955-Cells, Cultured, pubmed-meshheading:11451955-Cloning, Molecular, pubmed-meshheading:11451955-Coculture Techniques, pubmed-meshheading:11451955-Dose-Response Relationship, Drug, pubmed-meshheading:11451955-Enzyme-Linked Immunosorbent Assay, pubmed-meshheading:11451955-Glycoproteins, pubmed-meshheading:11451955-Humans, pubmed-meshheading:11451955-Mice, pubmed-meshheading:11451955-Mutation, pubmed-meshheading:11451955-Osteoclasts, pubmed-meshheading:11451955-Osteoprotegerin, pubmed-meshheading:11451955-Promoter Regions, Genetic, pubmed-meshheading:11451955-Protein Binding, pubmed-meshheading:11451955-Protein Isoforms, pubmed-meshheading:11451955-RNA, Messenger, pubmed-meshheading:11451955-Receptors, Cytoplasmic and Nuclear, pubmed-meshheading:11451955-Receptors, Tumor Necrosis Factor, pubmed-meshheading:11451955-Signal Transduction, pubmed-meshheading:11451955-Time Factors, pubmed-meshheading:11451955-Transcription, Genetic, pubmed-meshheading:11451955-Transfection, pubmed-meshheading:11451955-Transforming Growth Factor beta, pubmed-meshheading:11451955-beta-Galactosidase
pubmed:year
2001
pubmed:articleTitle
Stimulation of osteoprotegerin (OPG) gene expression by transforming growth factor-beta (TGF-beta). Mapping of the OPG promoter region that mediates TGF-beta effects.
pubmed:affiliation
Gene Regulation, Bone and Inflammation Research, Lilly Research Laboratories, Eli Lilly and Co., Indianapolis, Indiana 46285, USA.
pubmed:publicationType
Journal Article